Enable Injections develops and manufactures wearable drug delivery systems centered on the enFuse platform.
Enable Injections has raised $30.0M in total funding. The most recent round was Corporate Round. The last funding was announced in January 2026.
Enable Injections's investors include Sanofi, Oxford Finance LLC, Cincinnati Children’s, Magnetar Capital, GCM Grosvenor.
Enable Injections is headquartered in Cincinnati, United States.
Enable Injections develops and manufactures wearable drug delivery systems centered on the enFuse platform.
Enable Injections is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enable Injections — Funding & Investors." VCBacked, January 6, 2026, https://www.vcbacked.co/company/enable-injections. Accessed September 30, 2026.
VCBacked. (2026). Enable Injections — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/enable-injections
{{cite web |title=Enable Injections — Funding & Investors |url=https://www.vcbacked.co/company/enable-injections |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated